纖溶酶原激活物抑制因子1(PAI1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)
ELISA Kit DIY Materials for Plasminogen Activator Inhibitor 1 (PAI1)
SERPINE1; PLANH1; Serpin Peptidase Inhibitor Clade E Member 1; Nexin,Plasminogen Activator Inhibitor Type 1 Serpin E1; Endothelial plasminogen activator inhibitor
- 編號KSA532Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 試劑內(nèi)容包被抗體、檢測抗體、標(biāo)準(zhǔn)品、HRP標(biāo)記的鏈霉親和素、TMB底物、96孔板
- 可檢測樣本plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 可適用原理雙抗夾心酶聯(lián)免疫吸附試驗法測抗原
- 可檢測范圍12.5-800pg/mL
- 可適靈敏度5.1pg/mL
- 應(yīng)用Main materials for "Do It (ELISA Kit) Yourself".
- 下載英文說明書 中文說明書
- 規(guī)格96T*596T*1096T*2096T*5096T*100
- 價格¥ 5378¥ 8964¥ 16135¥ 31374¥ 53784
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
試劑盒中的抗體對纖溶酶原激活物抑制因子1(PAI1)具有高靈敏度和高特異性，經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
用法
1.用100μL每孔的工作濃度的包被抗體包被96孔板，4度孵育過夜或者37度孵育2小時；
2.洗板1次；
3.用200μL每孔的工作濃度的封閉液,37度孵育1.5小時；
4.洗板1次。酶標(biāo)板即可用于ELISA實驗，后續(xù)使用方法與ELISA同。
儲存
抗體，標(biāo)準(zhǔn)品和HRP標(biāo)記的鏈霉親和素在-20度保存，TMB需在4度保存，96孔板在室溫保存。所有組分保質(zhì)期為1年，試劑一旦開封，在4度保存時間為1個月。
配套試劑
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA532Hu02 | 纖溶酶原激活物抑制因子1(PAI1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA532Hu61 | 纖溶酶原激活物抑制因子1(PAI1)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA532Hu01 | 纖溶酶原激活物抑制因子1(PAI1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA532Hu61 | 纖溶酶原激活物抑制因子1(PAI1)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAA532Hu01 | 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA532Hu02 | 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體 | WB; IHC |
| LAA532Hu71 | 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAA532Hu81 | 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| MAA532Hu22 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | WB; IHC; ICC/IF |
| MAA532Hu24 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | WB; IHC |
| MAA532Hu27 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | IHC |
| MAA532Hu29 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA532Hu25 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA532Hu21 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | WB; IHC; ICC/IF |
| MAA532Hu26 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA532Hu28 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA532Hu23 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | WB; IHC |
| FAA532Hu04 | 抗纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | Flow cytometry. |
| FAA532Hu02 | 抗纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | Flow cytometry. |
| FAA532Hu06 | 抗纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | Flow cytometry. |
| FAA532Hu08 | 抗纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 | Flow cytometry. |
| LAA532Hu74 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAA532Hu76 | 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MEA532Hu | 纖溶酶原激活物抑制因子1(PAI1)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEA532Hu | 纖溶酶原激活物抑制因子1(PAI1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA532Hu | 纖溶酶原激活物抑制因子1(PAI1)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA532Hu | 纖溶酶原激活物抑制因子1(PAI1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSA532Hu01 | 纖溶酶原激活物抑制因子1(PAI1)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA532Hu01 | 纖溶酶原激活物抑制因子1(PAI1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Breast Cancer Research and Treatment | Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice[SpringerLink: f3w831267267p277] |
| Clin Appl Thromb Hemost. | Is There Any Association Between Thrombosis and Tissue Factor Pathway Inhibitor Levels in Patients With Vitamin D Deficiency?[Pubmed: 24203351] |
| Molecular Nutrition & Food Research | Trans‐fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll‐like receptors[PubMed: 25546502] |
| Archives of Physiology and Biochemistry | Activation of cardiac renin–angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder[Pubmed:26934364] |
| Naunyn-Schmiedeberg's Archives of Pharmacology | Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression[pubmed:27447455] |
| Environmental toxicology and pharmacology | Combined oral contraceptive and nitric oxide synthesis inhibition synergistically causes cardiac hypertrophy and exacerbates insulin resistance in female rats.[pubmed:28376377] |
| Annals of Clinical & Laboratory Science | Alteration of Hemostatic Parameters in Patients with Different Levels of Subclinical Hypothyroidism and the Effect of L-thyroxine Treatment[pubmed:28249913] |
| Pharmacological reports | Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent[pubmed:28349880] |
| Haematologica | Cytoprotective and pro-angiogenic functions of thrombomodulin are preserved in the C loop of the fifth epidermal growth factor-like domain[Pubmed:29903766] |
| Biomedicine & Pharmacotherapy | Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells[Pubmed:29775893] |
| Archives of?Physical?Medicine?and Rehabilitation | Impact of Regular Physical Activity on Adipocytokines and Cardiovascular Characteristics in Spinal Cord–Injured Subjects[Pubmed:29548578] |
| Marine Drugs | Anticoagulant and Antithrombotic Properties in Vitro and in Vivo of a Novel Sulfated Polysaccharide from Marine Green Alga Monostroma nitidum[Pubmed: 31027312] |
| Experimental and Therapeutic Medicine | IKKβ regulates the expression of coagulation and fibrinolysis factors through the NF?κB canonical pathway in LPS?stimulated alveolar epithelial cells type II[Pubmed: 31572531] |
| Phytomedicine | Sodium aescinate significantly suppress postoperative peritoneal adhesion by inhibiting the RhoA/ROCK signaling pathway[Pubmed: 32120245] |
| Sci Rep | Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis[Pubmed:35013379] |
| Phytomedicine | Multi-omics analysis reveals the mechanisms of action and therapeutic regimens of traditional Chinese medicine, Bufei Jianpi granules: Implication for COPD drug?…[Pubmed:35121390] |